The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Investigation

• Publication date

  2004-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI19656PMID 14722621PMCID PMC311433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

  2002cited by this paper
• Molecular pharmacology and modeling of vasopressin receptors.

  2002cited by this paper
• Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

  2002cited by this paper
• Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.

  2002cited by this paper
• The α1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction

  2002cited by this paper
• The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

  2002cited by this paper
• The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists.

  2001cited by this paper
• Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin.

  2001cited by this paper
• Glucocorticoid Negative Feedback Selectively Targets Vasopressin Transcription in Parvocellular Neurosecretory Neurons

  2000cited by this paper
• Selective Activation of the Hypothalamic Vasopressinergic System in Mice Deficient for the Corticotropin-Releasing Hormone Receptor 1 Is Dependent on Glucocorticoids* * This work was supported by the Volkswagen Stiftung (to F.H. and W.W.).

  2000cited by this paper
• Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids.

  2000cited by this paper
• CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation.

  1999cited by this paper
• Structure and sequence of the mouse V1a and V1b vasopressin receptor genes.

  1999cited by this paper
• The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

  1999cited by this paper
• Regulation of Adrenocortical Function by Vasopressin

  1998cited by this paper
• Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1

  1998cited by this paper
• Changes in adrenocorticotropic hormone (ACTH) release from the cultured anterior pituitary cells of streptozotocin-induced diabetic rats.

  1998cited by this paper
• New York, New York, USA

  1996cited by this paper
• Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor.

  1994cited by this paper
• Cloning and characterization of the human V3 pituitary vasopressin receptor

  1994cited by this paper
• In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.

  1994cited by this paper
• A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene.

  1993cited by this paper
• Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

  1993cited by this paper
• Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus.

  1992cited by this paper
• Molecular cloning and expression of a rat Via arginine vasopressin receptor

  1992cited by this paper
• Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

  1992cited by this paper
• Role of protein kinase-C in the adrenocorticotropin secretory response to arginine vasopressin (AVP) and the synergistic response to AVP and corticotropin-releasing factor by perifused rat anterior pituitary cells.

  1990cited by this paper
• Vasopressin and blood pressure.

  1988cited by this paper
• Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

  1986cited by this paper
• Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects.

  1985cited by this paper
• Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy.

  1984cited by this paper
• Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo.

  1983cited by this paper
• Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin

  1983cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper
• Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin.

  1979cited by this paper
• Behavioral despair in mice: a primary screening test for antidepressants.

  1977cited by this paper

• A Symmetric Systemic Challenge Elicits a Right-Biased Response Mediated by Vasopressin Signaling

  2026cites this paper
• The hypothalamic vasopressin circuit drives lateralized endocrine signaling.

  2026cites this paper
• Blunted arginine vasopressin secretion in individuals experiencing a major depressive episode with comorbid post‐traumatic stress disorder: Results from an exploratory study using copeptin as a surrogate marker

  2026cites this paper
• Aquaporin-4 Dysfunction in Depression: From Pathogenic Mechanisms to Novel Therapeutic Targeting

  2026cites this paper
• Inflammation and vasopressin hypersecretion in aging

  2025cites this paper
• Vasopressin and oxytocin receptors in GtoPdb v.2025.3

  2025cites this paper
• The Role of Supraoptic Hypothalamic Arginine Vasopressin Neurons in Aging-Associated Water Balance and Thermoregulatory Deficits

  2025cites this paper
• Arginine vasopressin and copeptin: comparative review and perspective in veterinary medicine

  2025cites this paper
• Beyond the Classical Axis: Metabolic “Pressure” on the Adrenal Gland?

  2025cites this paper
• Associations of water intake and Intra-Meal fluid consumption with obesity, insulin resistance, and predictors of cardiovascular diseases among Iranian women

  2025cites this paper
• Research Progress on the Structure and Function of Arginine Vasopressin and Its Receptor

  2025cites this paper
• Relationship between fluid intake, hydration status and cortisol dynamics in healthy, young adult males

  2025cites this paper
• Pharmacological associations of Central Serous Chorioretinopathy: Looking beyond corticosteroids.

  2025cites this paper
• A distinctive approach to comprehending regulatory signalling mechanisms underlying the hypothalamic‒pituitary‒adrenal (HPA) axis

  2025cites this paper
• High-Stakes Hormone: Vasopressin Use as a Last-Line Therapy for Shock in Pediatrics—A Narrative Review

  2025cites this paper
• Copeptin in the diagnosis and management of renal tubular disorders.

  2025cites this paper
• Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic intervention

  2024cites this paper
• The possible role of the vasopressin system in hematopoiesis

  2024cites this paper
• Hemodynamic Management with Vasopressin for Cardiovascular Surgery

  2024cites this paper
• Effect of vasopressin on brain and cardiac tissue during neonatal cardiopulmonary resuscitation of asphyxiated post-transitional piglets

  2024cites this paper
• Computer vision analysis of mother-infant interaction identified efficient pup retrieval in V1b receptor knockout mice.

  2024cites this paper
• The bilevel chamber revealed differential involvement of vasopressin and oxytocin receptors in female mouse sexual behavior

  2024cites this paper
• Long-term health outcomes associated with hydration status

  2024cites this paper
• Computer vision analysis of mother-infant interaction identified efficient pup retrieval in V1b vasopressin receptor knockout mice

  2024cites this paper
• Is mild dehydration a risk for progression of childhood chronic kidney disease?

  2024cites this paper
• Evidence for the contribution of vasopressin V1B receptors in the pathophysiology of depression.

  2024cites this paper
• V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor

  2024cites this paper
• Copeptin as a diagnostic and prognostic biomarker in pediatric diseases

  2024cites this paper
• An intact pituitary vasopressin system is critical for building a robust circadian clock in the suprachiasmatic nucleus

  2023cites this paper
• Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease

  2023influential citation
• Vasopressin and oxytocin receptors in GtoPdb v.2023.1

  2023cites this paper
• Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study

  2023cites this paper
• The association of copeptin with metabolic risk markers is modified by region of origin

  2023cites this paper
• Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment

  2023cites this paper
• Afectación renal en la enfermedad hepática crónica avanzada. Síndrome hepatorrenal

  2023cites this paper
• THIRSTY FOR FRUCTOSE: Arginine Vasopressin, Fructose, and the Pathogenesis of Metabolic and Renal Disease

  2022cites this paper
• Efficacy and Safety of Vasopressin Alone or in Combination With Catecholamines in the Treatment of Septic Shock: A Systematic Review

  2022cites this paper
• Renal Insufficiency in Patients with Cirrhosis.

  2022cites this paper
• High salt intake activates the hypothalamic–pituitary–adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice

  2022cites this paper
• ՋՈՒՐ ԵՎ ԱՌՈՂՋՈՒԹՅՈՒՆ

  2022cites this paper
• Hypo-Osmoregulatory Roles of Vasotocinergic and Isotocinergic Systems in the Intestines of Two European Sea Bass Lineages

  2022cites this paper
• Seasonal variation of vasopressin and its relevance for the winter peak of cardiometabolic disease: A pooled analysis of five cohorts

  2022cites this paper
• Copeptin Levels Before and After Transsphenoidal Surgery for Cushing Disease: A Potential Early Marker of Remission.

  2022cites this paper
• Oxytocin Facilitates Allomaternal Behavior under Stress in Laboratory Mice

  2022cites this paper
• Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking

  2021cites this paper
• A Review of Hepatorenal Syndrome

  2021cites this paper
• A Journey through the Early Evidence Linking Hydration to Metabolic Health

  2021cites this paper
• Recent advances in the understanding and management of hepatorenal syndrome

  2021cites this paper
• Investigation of possible underlying mechanisms behind water-induced glucose reduction in adults with high copeptin

  2021cites this paper
• Exercise-Induced Adrenocorticotropic Hormone Response Is Cooperatively Regulated by Hypothalamic Arginine Vasopressin and Corticotrophin-Releasing Hormone

  2021cites this paper
• Exploring the role of neuropeptides in depression and anxiety.

  2021cites this paper
• Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer 11C-TASP699

  2021cites this paper
• Water Intake and Markers of Hydration Are Related to Cardiometabolic Risk Biomarkers in Community-Dwelling Older Adults: A Cross-Sectional Analysis

  2021cites this paper
• Disorders of the Posterior Pituitary

  2021cites this paper
• The Biology of Vasopressin

  2021cites this paper
• Gq signaling in α cells is critical for maintaining euglycemia

  2021cites this paper
• CVR-2020-0297 High Sodium Intake, Glomerular Hyperfiltration and Protein Catabolism in Patients with Essential Hypertension

  2020cites this paper
• Hydration for health hypothesis: a narrative review of supporting evidence

  2020cites this paper
• The Effect of Acute Hypohydration on Indicators of Glycemic Regulation, Appetite, Metabolism and Stress: A Systematic Review and Meta-Analysis

  2020cites this paper
• Hepatorenal syndrome: pathophysiology, diagnosis, and management

  2020cites this paper
• High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension

  2020cites this paper
• Anterior Pituitary and Pars Intermedia Space

  2020cites this paper
• High water intake and low urine osmolality are associated with favorable metabolic profile at a population level: low vasopressin secretion as a possible explanation

  2020cites this paper
• Posterior Pituitary Hormones

  2020cites this paper
• Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.

  2019cites this paper
• AVPR1b variation and the emergence of adaptive phenotypes in Platyrrhini primates

  2019cites this paper
• What Makes Us Anxious: A Cross-Species Multi-omics Approach to the Biological Basis of Anxiety Disorders

  2019cites this paper
• Central Oxytocin alters Cortisol and Behavioral Responses of Guinea Pig Pups during Isolation in a Novel Environment.

  2019cites this paper
• SGLT2 Inhibition Increases Serum Copeptin in Young Adults with Type 1 Diabetes.

  2019cites this paper
• Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities

  2019cites this paper
• Dynamic Modulation of Mouse Locus Coeruleus Neurons by Vasopressin 1a and 1b Receptors

  2018cites this paper
• Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance

  2018cites this paper
• Modulation of male mouse sociosexual and anxiety-like behaviors by vasopressin receptors.

  2018cites this paper
• Water intake keeps type 2 diabetes away? Focus on copeptin

  2018cites this paper
• Effects of Arginine Vasopressin on Migration and Respiratory Burst Activity in Human Leukocytes

  2018cites this paper
• Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin: The H2O Metabolism Pilot Study

  2018cites this paper
• The Vasopressin System in the Risk of Diabetes and Cardiorenal Disease, and Hydration as a Potential Lifestyle Intervention

  2018cites this paper
• Hippocampus and Hypothalamus RNA-sequencing of WFS1-deficient Mice.

  2018cites this paper
• Exploring the impact of maternal obesity on offspring renal morphology and later life health

  2018cites this paper
• Plasma copeptin as a predictor of kidney disease

  2018cites this paper
• V1b vasopressin receptor trafficking and signaling: Role of arrestins, G proteins and Src kinase

  2018cites this paper
• The Effect of High-Fructose Corn syrup on Ethanol Taking, Seeking, and Palatability in Rats

  2018cites this paper
• Arginine vasopressin signaling in the suprachiasmatic nucleus on the resilience of circadian clock to jet lag.

  2017cites this paper
• Concomitant vasopressin and hydrocortisone therapy on short‐term hemodynamic effects and vasopressor requirements in refractory septic shock

  2017cites this paper
• Role of vasopressin V1a receptor in ∆9-tetrahydrocannabinol-induced cataleptic immobilization in mice

  2017cites this paper
• Intrauterine Wachstumsretardierung als lebenslanges Risiko für das Kind.

  2017cites this paper
• Vasopressin and metabolic disorders: translation from experimental models to clinical use

  2017cites this paper
• Structural and functional diversity of nonapeptide hormones from an evolutionary perspective: A review.

  2017cites this paper
• Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans

  2017cites this paper
• Distribution and chemical composition of estrogen receptor β neurons in the paraventricular nucleus of the female and male mouse hypothalamus

  2017influential citation
• Social Context, Stress, Neuropsychiatric Disorders, and the Vasopressin 1b Receptor

  2017cites this paper
• Cyclic 3',5'-adenosine monophosphate (cAMP) signaling in the anterior pituitary gland in health and disease.

  2017cites this paper
• The Pulsatility of ACTH Secretion in the Rat Anterior Pituitary Cell Perifusion System

  2017cites this paper
• Neuroendocrine Derangements in Early Septic Shock: Pharmacotherapy for Relative Adrenal and Vasopressin Insufficiency

  2017cites this paper
• Comparison of natural and artificial vasopressin deficiency: Why is the latter lethal?

  2017influential citation
• Common and diverse elements of ion channels and receptors underlying electrical activity in endocrine pituitary cells.

  2017cites this paper
• Neuroimmune Regulation in Health: Acute Febrile Illness and Healing

  2016cites this paper
• Corticotropin-Releasing Factor Receptors and Their Interacting Proteins: Functional Consequences

  2016influential citation
• Serum levels of copeptin are associated with type 2 diabetes and diabetic complications in Chinese population.

  2016cites this paper